Patients with psoriasis have a higher risk for synovitis on imaging than healthy individuals, according to a systematic ...

A new trial finds guselkumab is highly effective and well tolerated for moderate to severe scalp psoriasis in individuals ...

Based on those insights, medical education on screening tools such as the PHQ-2 could lead to improved care for psoriasis patients, including referral to psychiatric services as needed.

HealthDay News — Women have lower median Psoriasis Area and Severity Index (PASI) scores than men, according to a study published online March 24 in the American Journal of Clinical Dermatology ...

A greater proportion of patients with psoriasis in 1 or more special areas (43.3%) had a DLQI scores of 6 or above and PHQ-2 of 3 or higher vs patients without special area involvement (32.8%).

For patients with psoriasis, tools such as the Psoriasis Epidemiology Screening Tool can help predict the possibility of future psoriatic arthritis development, according to a study. It is ...

ORLANDO -- The TYK2 inhibitor deucravacitinib (Sotyktu) showed clinical potential in two diseases other than psoriasis, according to studies reported here.

MIAMI BEACH, Fla. — A novel machine learning model accurately estimated scores from a depression questionnaire from complete and partial clinical notes, per a poster at the American Society ...

Accropeutics’ drug hit the goals of a phase 2 psoriasis trial in China, prompting the biotech to “accelerate” the TYK2/JAK1 inhibitor’s development.

HealthDay News — Increased coronary artery calcium, indicative of asymptomatic coronary atherosclerosis, is apparent in patients with psoriasis, and similar to that seen in patients with type 2 ...